Cormorant Asset Management’s Keros Therapeutics KROS Stock Holding History

Cormorant Asset Management’s Portfolio KROS Stock Details KROS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$4.8M	Hold
2022 Q3	$3.76M	Hold
2022 Q2	$2.76M	Hold
2022 Q1	$5.44M	Sell
2021 Q4	$8.78M	Buy